Compile Data Set for Download or QSAR
Report error Found 383 Enz. Inhib. hit(s) with all data for entry = 9230
TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450855BDBM450855(US10676469, Compound 113 | US11124504, Cpd. No. 11...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450854BDBM450854(US10676469, Compound 112 | US11124504, Cpd. No. 11...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450886BDBM450886(US10676469, Compound 157 | US11124504, Cpd. No. 15...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450947BDBM450947(US10676469, Compound 191 | US11124504, Cpd. No. 19...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450946BDBM450946(US10676469, Compound 190 | US11124504, Cpd. No. 19...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450831BDBM450831(US10676469, Compound 89 | US11124504, Cpd. No. 89)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450862BDBM450862(US10676469, Compound 120 | US11124504, Cpd. No. 12...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450861BDBM450861(US10676469, Compound 119 | US11124504, Cpd. No. 11...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450828BDBM450828(US10676469, Compound 86 | US11124504, Cpd. No. 86)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450952BDBM450952(US10676469, Compound 215 | US11124504, Cpd. No. 21...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450950BDBM450950(US10676469, Compound 213 | US11124504, Cpd. No. 21...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450965BDBM450965(US10676469, Compound 247 | US11124504, Cpd. No. 24...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50531908BDBM50531908(US10676469, Compound 142 | Btrx-335140 | CYM-53093...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450934BDBM450934(US10676469, Compound 174 | US11124504, Cpd. No. 17...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450964BDBM450964(US10676469, Compound 246 | US11124504, Cpd. No. 24...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450901BDBM450901(US10676469, Compound 195 | US11124504, Cpd. No. 19...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450959BDBM450959(US10676469, Compound 243 | US11124504, Cpd. No. 24...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450833BDBM450833(US10676469, Compound 91 | US11124504, Cpd. No. 91)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450932BDBM450932(US10676469, Compound 172 | US10676469, Compound 22...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450832BDBM450832(US10676469, Compound 90 | US11124504, Cpd. No. 90)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50531921BDBM50531921(US10676469, Compound 148 | CHEMBL4544914 | US11124...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450939BDBM450939(US10676469, Compound 183 | US11124504, Cpd. No. 18...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450843BDBM450843(US10676469, Compound 101 | US11124504, Cpd. No. 10...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50531919BDBM50531919(US10676469, Compound 146 | CHEMBL4549826 | US11124...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450938BDBM450938(US10676469, Compound 182 | US11124504, Cpd. No. 18...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450842BDBM450842(US10676469, Compound 100 | US11124504, Cpd. No. 10...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50531916BDBM50531916(US10676469, Compound 145 | CHEMBL4456582 | US11124...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450937BDBM450937(US10676469, Compound 181 | US11124504, Cpd. No. 18...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450841BDBM450841(US10676469, Compound 99 | US11124504, Cpd. No. 99)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50531915BDBM50531915(US10676469, Compound 144 | CHEMBL4440683 | US11124...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450936BDBM450936(US10676469, Compound 176 | US11124504, Cpd. No. 17...)
Affinity DataIC50: 1nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450823BDBM450823(US10676469, Compound 38 | US11124504, Cpd. No. 38)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450887BDBM450887(US10676469, Compound 158 | US11124504, Cpd. No. 15...)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450948BDBM450948(US10676469, Compound 211 | US11124504, Cpd. No. 21...)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450822BDBM450822(US10676469, Compound 37 | US11124504, Cpd. No. 37)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450914BDBM450914(US10676469, Compound 210 | US11124504, Cpd. No. 21...)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450885BDBM450885(US10676469, Compound 156 | US11124504, Cpd. No. 15...)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450819BDBM450819(US10676469, Compound 34 | US10676469, Compound 228...)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450818BDBM450818(US10676469, Compound 33 | US11124504, Cpd. No. 33)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450817BDBM450817(US10676469, Compound 32 | US11124504, Cpd. No. 32)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450881BDBM450881(US10676469, Compound 152 | US11124504, Cpd. No. 15...)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450816BDBM450816(US10676469, Compound 31 | US11124504, Cpd. No. 31)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450880BDBM450880(US10676469, Compound 151 | US11124504, Cpd. No. 15...)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450957BDBM450957(US10676469, Compound 237b | US11124504, Cpd. No. 2...)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450895BDBM450895(US10676469, Compound 177 | US11124504, Cpd. No. 17...)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450956BDBM450956(US10676469, Compound 237a | US11124504, Cpd. No. 2...)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450830BDBM450830(US10676469, Compound 88 | US11124504, Cpd. No. 88)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450955BDBM450955(US10676469, Compound 236b | US11124504, Cpd. No. 2...)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450954BDBM450954(US10676469, Compound 236a | US11124504, Cpd. No. 2...)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Blackthorn Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 450819BDBM450819(US10676469, Compound 34 | US10676469, Compound 228...)
Affinity DataIC50: 5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
US Patent

Displayed 1 to 50 (of 383 total ) | Next | Last >>
Jump to: